[144] Innovative Eyewear, Inc. Series A Warrants 8/16/27 SEC Filing

Rhea-AI Filing Summary

Form 144 notice for Innovative Eyewear, Inc. (symbol LUCYW) reports a proposed sale of 2,225 common shares through Raymond James on 08/19/2025 with an aggregate market value of $4,421.80. The filing shows the securities were acquired the same day as an RSU grant (8,200 units granted; 7,200 units listed as acquired) and payment is listed as cash. The issuer's outstanding shares are stated as 4,574,602. Several standard filer and issuer contact fields are blank in the submission.

Insights

Securities Analyst

TL;DR: Routine insider sale notice; small disclosed value and clear acquisition source (RSU).

The Form 144 documents a proposed sale of 2,225 common shares via Raymond James with a modest aggregate value of $4,421.80. The filing specifies the shares derive from an RSU grant dated 08/19/2025 and lists cash as the payment method. There are no reported prior sales in the past three months. From a trading-disclosure perspective this is a routine compliance filing that provides transparency about an insider-derived sale; it does not by itself indicate material corporate developments.

Corporate Governance Expert

TL;DR: The notice fulfills Rule 144 disclosure for a sale of shares issued as RSUs but lacks some filer contact details.

The filing satisfies the mechanics of Rule 144 notification by identifying the broker, class, quantity, and acquisition method (RSU grant). It also includes the required representation about lack of undisclosed material adverse information. However, several issuer and filer contact fields appear blank, which may limit immediate traceability; that omission is administrative rather than substantive regarding the transaction itself.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates 880 Carillon Parkway St. Petersburg FL 33716	2225	4421.80	4574602	08/19/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/19/2025	RSU Grant	Issuer			7200	08/19/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for Innovative Eyewear (LUCYW) disclose?

The notice discloses a proposed sale of 2,225 common shares through Raymond James on 08/19/2025 with an aggregate market value of $4,421.80.

How were the shares being sold acquired according to the filing?

The filing states the shares were acquired on 08/19/2025 as an RSU grant, with 7,200 securities listed as acquired and cash indicated as the payment method.

Does the Form 144 report any securities sold in the past three months?

The filing indicates Nothing to Report for securities sold during the past three months by the person for whose account the securities are to be sold.

Who is the broker named in the Form 144?

The broker listed is Raymond James & Associates, 880 Carillon Parkway, St. Petersburg, FL 33716.

How many shares outstanding does the filing list for the issuer?

The filing lists 4,574,602 shares outstanding for the issuer.